Interconversion of multiple forms of tyrosine aminotransferase in vitro and in vivo in cultured hepatoma cells.
Corticosteroid-induced tyrosine aminotransferase (EC 2.6.1.5) from cultured hepatoma cells was separated by carboxymethyl-Sephadex chromatography into three molecular forms resembling those described previously in the rat liver. Enzyme forms were isolated and used as purified substrates to examine their in vitro interconversion by various subcellular fractions. Isolated form III was converted to forms II and I, and isolated form II was converted to form I by the coarse particulate fraction sedimenting at 1000 X g. This activity was inhibited by the serine enzyme inhibitor phenylmethane sulfonyl fluoride or by raising the pH to 8.7. Conversion of enzyme forms in vitro in the opposite direction (I leads to II leads to III) could not be detected. The distribution of enzyme forms in vivo was examined by the use of experimental conditions that prevent their in vitro interconversion during cell extraction. Tyrosine aminotransferase extracted from cell subjected to various treatments that affect the rates of enzyme synthesis or degradation existed always predominantly as form III. It appears, therefore, that multiple forms of tyrosine aminotransferase are not related to the turnover of this enzyme in vivo.
D006528:Carcinoma, Hepatocellular / Q000201:enzymology*; D002460:Cell Line; D003907:Dexamethasone / Q000494:pharmacology; D004790:Enzyme Induction / Q000187:drug effects; D007527:Isoenzymes / Q000302:isolation & purification / Q000378:metabolism*; D008113:Liver Neoplasms; D009374:Neoplasms, Experimental / Q000201:enzymology; D013347:Subcellular Fractions / Q000201:enzymology; D014444:Tyrosine Transaminase / Q000302:isolation & purification / Q000378:metabolism*
D007527:Isoenzymes; D003907:Dexamethasone; D014444:Tyrosine Transaminase